Showing results (291-300 of 1,271) with videos related to
Sort By:
Pageof 128
Psychopharmacology Bulletin|October 26, 2002
Risperidone: review of its therapeutic utility in depressionJ E Myers, M E ThasePsychopharmacology Bulletin|October 26, 2002
The 5-HT1B receptor: behavioral implicationsM S Clark, J F NeumaierPsychopharmacology Bulletin|October 26, 2002
An explanation of the second-dose effect in pharmacokinetics and its meaning for clinical psychopharmacologyC L DeVane, H L ListonPsychopharmacology Bulletin|October 26, 2002
Neuroleptic malignant syndrome due to olanzapineK L Hall, W H Taylor, M R WarePsychopharmacology Bulletin|October 26, 2002
An evidence-based review of psychosocial treatments for bipolar disorderM S BauerPsychopharmacology Bulletin|October 26, 2002
Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's diseaseT E Gillen, K M Gregg, H Yuan, et al.Psychopharmacology Bulletin|March 13, 2019
Administration of Sub-anesthetic Dose of Ketamine and Electroconvulsive Treatment on Alternate Week Days in Patients with Treatment Resistant Depression: A Double Blind Placebo Controlled TrialMurat Altinay, Harish Karne, Amit AnandPsychopharmacology Bulletin|March 13, 2019
Akathisia Induced by Abrupt Withdrawal of Risperidone: A Case ReportGangaparameswari Soundarrajan, Bharti Chogtu, Vybhava Krishna, et al.Psychopharmacology Bulletin|December 10, 2021
Selective Serotonin Reuptake Inhibitors and Nutraceutical Combination in Major Depression Disorder: A Case-Control StudyMarta Ielmini, Ivano Caselli, Francesca Ceccon, et al.Pageof 128